Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey W Clark

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Cancer Discovery|May 16, 2012
Drug interactions: the importance of looking inside cancer cellsJeffrey W Clark
Expert Opinion on Investigational Drugs|December 24, 2005
RubitecanJeffrey W Clark
Molecular Phylogenetics and Evolution|December 10, 2002
Phylogenetic analysis of Blattabacterium, endosymbiotic bacteria from the wood roach, Cryptocercus (Blattodea: Cryptocercidae), including a description of three new speciesJeffrey W Clark, Srinivas Kambhampati
Current Opinion in Pulmonary Medicine|April 27, 2018
Recent progress in systemic treatment for lung cancerJeffrey W Clark, Dan L Longo
Cancer|March 15, 2008
Systemic therapy for metastatic colorectal cancer: current questionsDan S Zuckerman, Jeffrey W Clark
Oncology (Williston Park, N.Y.)|January 16, 2004
Update on combined-modality treatment options for pancreatic cancerChristopher G Willett, Jeffrey W Clark
The Oncologist|January 17, 2009
Commentary: Sorafenib use in patients with advanced hepatocellular carcinoma and underlying Child-Pugh B cirrhosis: evidence and controversyAndrew X Zhu, Jeffrey W Clark
The New England Journal of Medicine|January 5, 2017
Limits to Precision Cancer MedicineJeffrey W Clark, Bruce A Chabner
Lancet (London, England)|June 5, 2003
Using "rationally designed drugs" rationallyJim Brugarolas, Jeffrey W Clark, Bruce Chabner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Targeted agents: the rules of combinationEunice L Kwak, Jeffrey W Clark, Bruce Chabner
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Cancer Discovery|May 16, 2012
Drug interactions: the importance of looking inside cancer cellsJeffrey W Clark
Expert Opinion on Investigational Drugs|December 24, 2005
RubitecanJeffrey W Clark
Molecular Phylogenetics and Evolution|December 10, 2002
Phylogenetic analysis of Blattabacterium, endosymbiotic bacteria from the wood roach, Cryptocercus (Blattodea: Cryptocercidae), including a description of three new speciesJeffrey W Clark, Srinivas Kambhampati
Current Opinion in Pulmonary Medicine|April 27, 2018
Recent progress in systemic treatment for lung cancerJeffrey W Clark, Dan L Longo
Cancer|March 15, 2008
Systemic therapy for metastatic colorectal cancer: current questionsDan S Zuckerman, Jeffrey W Clark
Oncology (Williston Park, N.Y.)|January 16, 2004
Update on combined-modality treatment options for pancreatic cancerChristopher G Willett, Jeffrey W Clark
The Oncologist|January 17, 2009
Commentary: Sorafenib use in patients with advanced hepatocellular carcinoma and underlying Child-Pugh B cirrhosis: evidence and controversyAndrew X Zhu, Jeffrey W Clark
The New England Journal of Medicine|January 5, 2017
Limits to Precision Cancer MedicineJeffrey W Clark, Bruce A Chabner
Lancet (London, England)|June 5, 2003
Using "rationally designed drugs" rationallyJim Brugarolas, Jeffrey W Clark, Bruce Chabner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Targeted agents: the rules of combinationEunice L Kwak, Jeffrey W Clark, Bruce Chabner
Pageof 21